Collective vs Shed: Which GLP-1 Provider Is Better?
Short answer: Shed scores higher on our rubric, 7.8/10 against 4.6/10. Full reasoning, pricing and the cases where the other one wins are below.
Shed beats Collective overall, scoring 7.8/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; Shed is from $159/mo. Choose Collective for cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership. Choose Shed for users who want a price that stays flat as the dose escalates, on a simple compounded glp-1 program.
A side-by-side look at Collective and Shed to help you decide. We compare them on:
- •Starting price and billing period
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Collective
#32 of 36CollectiveOS is a membership telehealth platform operated by Health For Everyone Inc. It advertises compounded semaglutide at $59 a month and compounded tirzepatide at $69 a month, with the same medication price at every dose and no multi-month medication commitment. The required membership is free for 21 days and then costs $199 a year. That makes the first-year cash totals $907 for semaglutide and $1,027 for tirzepatide before any technology transaction fee that the terms permit but do not price. Membership includes clinician review, unlimited doctor messaging, nutrition and lifestyle support, and two-day express cold shipping. Collective links to LegitScript's public checker and identifies MDIntegrations as an example clinician network, but it does not publicly name a dispensing pharmacy or list the states it serves.
Visit CollectiveShed
#7 of 36Newer GLP-1 provider built around simplicity and flat pricing, with same day approval advertised, one price at any dose, and compounded semaglutide from $159 a month on the 12-month plan.
Visit Shed| Feature | Collective | Shed |
|---|---|---|
| Why each one | Very low month-to-month medication pricing that remains flat across doses, funded through a separately disclosed annual membership. | One flat price at any dose. Shed holds the monthly price steady as the dose escalates, with semaglutide from $159 and tirzepatide from $239 on the 12-month plans and provider care included. |
| Our Score | 4.6/10 | 7.8/10 |
| Headline Price | from $59/mo | from $159/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | Cash-pay. Collective says medication and membership are HSA/FSA eligible; eligibility and reimbursement depend on the account and expense. | No |
| Best For | Cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership | Users who want a price that stays flat as the dose escalates, on a simple compounded GLP-1 program |
| Watch out for | The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial | Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure. |
| Ranking | #32 | #7 |
| Get started | Visit Collective | Visit Shed |
Pros & Cons Compared
Collective
Pros
- +$59/mo compounded semaglutide and $69/mo compounded tirzepatide, with the medication price advertised as flat at every dose
- +Medication is billed month to month rather than through a required multi-month medication prepayment
- +Two-day express cold shipping, clinician review, unlimited doctor messaging, and nutrition and lifestyle support are included
- +The public site links certificate 50716874 to LegitScript's verification checker
- +The legal entity and MDIntegrations clinician-network relationship are disclosed in the legal pages
Cons
- −The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial
- −The terms permit a nominal technology transaction fee for each electronic prescription but publish no amount
- −No dispensing pharmacy, individual clinician, medical director, or public state-availability list is named
- −The annual membership auto-renews and is generally non-refundable, with no partial-period refunds
- −Only 9 Trustpilot reviews at 4.1/5 when checked September 15, 2026, too few for a mature reputation signal
- −Cash-pay compounded medications only; no brand-name Wegovy or Zepbound and no insurance or prior-authorization service
Shed
Pros
- +One flat price at any dose, Shed's pricing page states the monthly price never rises as the dose escalates
- +$199/mo is competitively priced for an all-inclusive compounded program with good support
- +Onboarding is fully online and asynchronous in many states, with same day approval advertised, though Shed says some states require a video visit before treatment
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
- −Short track record and thin published outcome data. A founding date is not shown on the site's about, contact, terms or FAQ pages (rendered check 2026-09-03), and the best evidence available is a 4.7 Trustpilot score across 1,129 reviews on a profile claimed in April 2025
- −Shed does not bill insurance, so the compounded program is cash pay, though it accepts HSA and FSA cards, posts downloadable receipts for reimbursement, and includes prior authorization and appeals support on the brand name route
- −Clinical support is responsive (replies typically within 24 hours) but less proactive than premium platforms; a $49.99/mo premium coaching add-on covers those who want higher touch
Our Verdict
Shed edges out Collective with a score of 7.8/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; Shed is from $159/mo. Shed offers both brand-name and compounded medications, giving you more flexibility.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Collective and Shed.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Collective and Hers$188 first month, then $298/mo
- Compare Collective and Galafrom $149/mo
- Compare Collective and Wellorithmfrom $147/mo
- Compare Shed and MEDVi$179 first month, then $299/mo
- Compare Shed and Foundpublished $148/mo; total not verified
- Compare Shed and Eden Health GLP-1$99/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Collective legit and is Shed legit, with the verification evidence behind each answer.
Our pick of these two: Shed · 7.8/10